Search

everythinglearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Male mice with FGF5 mutations grow longer hair than females.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Amygdalin in Persicae Semen may help treat hair loss by promoting hair growth and regulating key pathways.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Intersex frogs have different brain gene activity related to sex and thyroid hormones.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

Fenugreek extract may help treat benign prostatic hyperplasia.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.